December 14, 2023
Tag: Cancer Genetics Research Program
December 1, 2023
Cancer center researchers to present latest findings at international breast cancer meeting
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
November 17, 2023
Scientists piece together DNA repair pathway implicated in breast, ovarian, and prostate cancers
Researchers have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer and prostate cancer.
November 16, 2023
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
April 11, 2023
Perou elected as fellow of the American Association for Cancer Research Academy
The AACR has elected Charles Perou, PhD, as a fellow to the AACR Academy. Members of this year’s class will be formally recognized at the AACR’s annual meeting.
April 10, 2023
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
March 17, 2023
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
January 19, 2023
Ian Davis awarded $1 million by V Foundation
UNC Lineberger's Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
January 9, 2023
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.